Given the prominent role of s-IgA in immune defense on mucosal surfaces and the frequency with which infections are initiated on these surfaces, s-IgA affords a pathway by which higher plasma glucose levels might increase susceptibility to infectious diseases in DM individuals. Here, CD79A is linked to infectious disease.